|
Pediatric Heart Transplants
Pediatric
heart transplantation is safe and can even be
performed on infants with otherwise lethal cardiac conditions. Most patients
are able to recover and return to society in a productive manner.
Congenital heart defects that could be considered for transplantation include:
- Hypoplastic left heart syndrome
- Single ventricle with hypoplasia of the aortic outflow tract
- Atrioventricular canal defect
- Truncus arteriosus
Hypoplastic left heart syndrome accounts for one-to-two percent of all
congenital heart disease and is the most common cause of death from a cardiac
defect during the first month of life. These infants can benefit from an infant
heart transplant program.
Transplantation is the only treatment that offers hope to infants with irreversible
cardiomyopathies. Currently, the indication for the vast majority of pediatric heart
recipients over the age of one year is cardiomyopathy.
Infant transplant patients are evaluated in the neonatal intensive care unit or
pediatric intensive care unit at Shands at the University of Florida. Once accepted
for transplantation, the infant remains at Shands at UF until transplantation.
Infants are at significant risk of rejection, infection and developing accelerated coronary
artery disease after heart transplantation.
Infants receive endomyocardial biopsies at regular intervals to check for rejection.
Older children and adults receive endomyocardial biopsies more frequently than infants.
Families must stay within one hour's driving distance from the hospital for the first
two-to-four months following transplantation due to the frequency and complexity of outpatient
visits.
Statistics
Success rate and various other statistics regarding the Shands Transplant Center at UF are
available from the Scientific Registry of Transplant Recipients at
http://www.ustransplant.org.
Related Links
Information
For more information about the Shands Transplant Center Heart Transplant Program or to make a referral,
please call 352.265.0751. |